Download FREE Report Sample
Download Free sampleNovel Oral AntiCoagulants Market contains market size and forecasts of Novel Oral AntiCoagulants (NOAC) in global, including the following market information:
Global Novel Oral AntiCoagulants (NOAC) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Novel Oral AntiCoagulants (NOAC) Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Novel Oral AntiCoagulants (NOAC) companies in 2021 (%)
The global Novel Oral AntiCoagulants (NOAC) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Direct Thrombin Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Novel Oral AntiCoagulants (NOAC) include Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, Daiichi Sankyo, Armatheon, Aspen, AstraZeneca and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Novel Oral AntiCoagulants (NOAC) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Oral AntiCoagulants (NOAC) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) Market Segment Percentages, by Type, 2021 (%)
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors
Global Novel Oral AntiCoagulants (NOAC) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) Market Segment Percentages, by Application, 2021 (%)
Deep Vein Thrombosis (DVT)
Pulmonary Embolism
Acute Coronary Syndrome
Hemodialysis
Others
Global Novel Oral AntiCoagulants (NOAC) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Novel Oral AntiCoagulants (NOAC) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Novel Oral AntiCoagulants (NOAC) revenues share in global market, 2021 (%)
Key companies Novel Oral AntiCoagulants (NOAC) sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Novel Oral AntiCoagulants (NOAC) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Daiichi Sankyo
Armatheon
Aspen
AstraZeneca
Bayer
Cellceutix
Cosmo Pharmaceuticals
CSL Behring
Eisai
GSK
Marathon Pharmaceuticals
Ockham Biotech
Perosphere
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
